c-myc gene expression in human cells is controlled by glucose

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• The c-myc oncogene plays a crucial role in normal cell growth and differentiation.
• Understanding gene regulation by nutrient availability is vital for cell biology research.

Purpose of the Study:

• To investigate the effect of glucose concentration on c-myc oncogene expression in human cell lines.
• To determine if glucose metabolism is required for modulating c-myc expression.
• To compare the regulation of c-myc and insulin receptor gene expression by glucose.

Main Methods:

• Culturing human cell lines (IM9, HepG2) at varying glucose concentrations (5.5 mM vs. 25 mM).
• Measuring c-myc mRNA levels using quantitative methods.
• Utilizing metabolizable (D-fructose) and non-metabolizable (3-ortho-methylglucose) sugars.
• Treating cells with specific agents (PMA, dexamethasone) and analyzing gene expression.

Main Results:

• Low glucose (5.5 mM) increased c-myc mRNA levels 3-4 fold compared to high glucose (25 mM).
• D-fructose mimicked glucose in reducing c-myc expression, while 3-ortho-methylglucose had no effect.
• Glucose concentration modulated the response of c-myc to external stimuli like PMA and dexamethasone.
• Previously, glucose was shown to enhance insulin receptor gene expression.

Conclusions:

• Glucose concentration inversely controls the expression of c-myc and insulin receptor genes.
• Metabolizable glucose is essential for regulating c-myc expression.
• These findings highlight glucose's critical role in orchestrating genes involved in eukaryotic cell growth and differentiation.